Kovai Medical Center and Hospital Limited
Kovai Medical Center and Hospital Limited Fundamental Analysis
Kovai Medical Center and Hospital Limited (KOVAI.BO) shows strong financial fundamentals with a PE ratio of 24.05, profit margin of 15.43%, and ROE of 21.75%. The company generates $15.3B in annual revenue with strong year-over-year growth of 12.43%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 67.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze KOVAI.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentKOVAI.BO demonstrates superior asset utilization.
Valuation Score
ModerateKOVAI.BO shows balanced valuation metrics.
Growth Score
ExcellentKOVAI.BO delivers strong and consistent growth momentum.
Financial Health Score
ExcellentKOVAI.BO maintains a strong and stable balance sheet.
Profitability Score
ModerateKOVAI.BO maintains healthy but balanced margins.
Key Financial Metrics
Is KOVAI.BO Expensive or Cheap?
P/E Ratio
KOVAI.BO trades at 24.05 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, KOVAI.BO's PEG of 7.63 indicates potential overvaluation.
Price to Book
The market values Kovai Medical Center and Hospital Limited at 4.77 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 11.81 times EBITDA. This signals the market has high growth expectations.
How Well Does KOVAI.BO Make Money?
Net Profit Margin
For every $100 in sales, Kovai Medical Center and Hospital Limited keeps $15.43 as profit after all expenses.
Operating Margin
Core operations generate 21.26 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.75 in profit for every $100 of shareholder equity.
ROA
Kovai Medical Center and Hospital Limited generates $12.30 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Kovai Medical Center and Hospital Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Kovai Medical Center and Hospital Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
KOVAI.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
24.05
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
7.63
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.77
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.71
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.34
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.26
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.22
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.20
vs 25 benchmark
How KOVAI.BO Stacks Against Its Sector Peers
| Metric | KOVAI.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 24.05 | 29.45 | Better (Cheaper) |
| ROE | 21.75% | 779.00% | Weak |
| Net Margin | 15.43% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.34 | 0.26 | Weak (High Leverage) |
| Current Ratio | 1.26 | 4.65 | Neutral |
| ROA | 12.30% | -19344.00% (disorted) | Strong |
KOVAI.BO outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Kovai Medical Center and Hospital Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
96.94%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
120.91%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
113.00%
Industry Style: Defensive, Growth, Innovation
High Growth